Insider Transactions in Q1 2022 at Elanco Animal Health Inc (ELAN)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 05
2022
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
10,688
-1.4%
|
$288,576
$27.95 P/Share
|
|
Mar 02
2022
|
James M Meer CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
281
-1.43%
|
$8,149
$29.0 P/Share
|
|
Mar 02
2022
|
David Alan Urbanek |
SELL
Payment of exercise price or tax liability
|
Direct |
961
-1.03%
|
$27,869
$29.0 P/Share
|
|
Mar 02
2022
|
David S Kinard |
SELL
Payment of exercise price or tax liability
|
Direct |
874
-0.92%
|
$25,346
$29.0 P/Share
|
|
Mar 02
2022
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
8,879
-1.15%
|
$257,491
$29.0 P/Share
|
|
Mar 02
2022
|
Ramiro Martin Cabral |
SELL
Payment of exercise price or tax liability
|
Direct |
1,251
-1.49%
|
$36,279
$29.0 P/Share
|
|
Mar 02
2022
|
Todd S. Young |
SELL
Payment of exercise price or tax liability
|
Direct |
2,135
-1.75%
|
$61,915
$29.0 P/Share
|
|
Mar 02
2022
|
R David Hoover |
BUY
Open market or private purchase
|
Indirect |
5,000
+4.17%
|
$145,000
$29.0 P/Share
|
|
Mar 01
2022
|
James M Meer CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
383
-1.92%
|
$10,724
$28.94 P/Share
|
|
Mar 01
2022
|
James M Meer CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,955
+12.88%
|
-
|
|
Mar 01
2022
|
Kapila K Anand |
BUY
Open market or private purchase
|
Direct |
1,000
+3.51%
|
$28,000
$28.48 P/Share
|
|
Mar 01
2022
|
Ellen De Brabander |
BUY
Grant, award, or other acquisition
|
Direct |
14,496
+19.42%
|
-
|
|
Mar 01
2022
|
David Alan Urbanek |
SELL
Payment of exercise price or tax liability
|
Direct |
1,800
-1.89%
|
$50,400
$28.94 P/Share
|
|
Mar 01
2022
|
David Alan Urbanek |
BUY
Grant, award, or other acquisition
|
Direct |
10,341
+9.81%
|
-
|
|
Mar 01
2022
|
Marcela A. Kirberger |
BUY
Grant, award, or other acquisition
|
Direct |
10,583
+35.59%
|
-
|
|
Mar 01
2022
|
David S Kinard |
SELL
Payment of exercise price or tax liability
|
Direct |
1,724
-1.77%
|
$48,272
$28.94 P/Share
|
|
Mar 01
2022
|
David S Kinard |
BUY
Grant, award, or other acquisition
|
Direct |
8,665
+8.18%
|
-
|
|
Mar 01
2022
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
5,031
-0.65%
|
$140,868
$28.94 P/Share
|
|
Mar 01
2022
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
88,114
+10.18%
|
-
|
|
Mar 01
2022
|
De Simas Jose Manuel Correia |
SELL
Payment of exercise price or tax liability
|
Direct |
573
-2.56%
|
$16,044
$28.94 P/Share
|
|
Mar 01
2022
|
De Simas Jose Manuel Correia |
BUY
Grant, award, or other acquisition
|
Direct |
5,123
+18.65%
|
-
|
|
Mar 01
2022
|
Ramiro Martin Cabral |
SELL
Payment of exercise price or tax liability
|
Direct |
1,892
-2.2%
|
$52,976
$28.94 P/Share
|
|
Mar 01
2022
|
Ramiro Martin Cabral |
BUY
Grant, award, or other acquisition
|
Direct |
12,699
+12.86%
|
-
|
|
Mar 01
2022
|
Todd S. Young |
SELL
Payment of exercise price or tax liability
|
Direct |
3,747
-2.98%
|
$104,916
$28.94 P/Share
|
|
Mar 01
2022
|
Todd S. Young |
BUY
Grant, award, or other acquisition
|
Direct |
21,683
+14.7%
|
-
|
|
Mar 01
2022
|
R David Hoover |
BUY
Open market or private purchase
|
Indirect |
5,000
+4.35%
|
$140,000
$28.66 P/Share
|
|
Feb 22
2022
|
James M Meer CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,263
-6.91%
|
$31,575
$25.98 P/Share
|
|
Feb 22
2022
|
James M Meer CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
3,683
+16.76%
|
-
|
|
Feb 22
2022
|
Todd S. Young |
SELL
Payment of exercise price or tax liability
|
Direct |
22,557
-17.8%
|
$563,925
$25.98 P/Share
|
|
Feb 22
2022
|
Todd S. Young |
BUY
Grant, award, or other acquisition
|
Direct |
55,205
+30.35%
|
-
|
|
Feb 22
2022
|
David Alan Urbanek |
SELL
Payment of exercise price or tax liability
|
Direct |
10,305
-10.84%
|
$257,625
$25.98 P/Share
|
|
Feb 22
2022
|
David Alan Urbanek |
BUY
Grant, award, or other acquisition
|
Direct |
24,841
+20.71%
|
-
|
|
Feb 22
2022
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
92,948
-11.88%
|
$2,323,700
$25.98 P/Share
|
|
Feb 22
2022
|
Jeffrey N Simmons PRESIDENT, CEO AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
229,655
+22.69%
|
-
|
|
Feb 22
2022
|
David S Kinard |
SELL
Payment of exercise price or tax liability
|
Direct |
9,400
-9.59%
|
$235,000
$25.98 P/Share
|
|
Feb 22
2022
|
David S Kinard |
BUY
Grant, award, or other acquisition
|
Direct |
22,598
+18.74%
|
-
|
|
Feb 22
2022
|
Ramiro Martin Cabral |
SELL
Payment of exercise price or tax liability
|
Direct |
13,331
-15.37%
|
$333,275
$25.98 P/Share
|
|
Feb 22
2022
|
Ramiro Martin Cabral |
BUY
Grant, award, or other acquisition
|
Direct |
32,339
+27.16%
|
-
|
|
Jan 03
2022
|
James M Meer CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
3,540
+19.51%
|
-
|